Literature DB >> 28597213

[3-D mapping of ventricular tachycardia in patients with dilative cardiomyopathy].

Daniel Steven1, Jan-Hendrik van den Bruck2, Jakob Lüker2, Tobias Plenge2, Arian Sultan2.   

Abstract

Catheter ablation of ventricular tachycardia (VT) is gaining in importance. The current guidelines suggest considering catheter ablation for VT even in patients with a single sustained and documented episode. This is also underlined by recent data indicating that absence of VT predicts lower mortality and longer transplant-free survival. The majority of patients with VTs have a history of prior myocardial infarction; in a smaller proportion, patients present with dilated cardiomyopathy. The latter has a less structured scar pattern which makes it more complicated to apply efficient ablation strategies. Data have shown that the probability of VT recurrence after catheter ablation is higher and an epicardial access more frequently required. Algorithms and strategies to improve catheter ablation results have been developed and evaluated especially on patients with dilated cardiomyopathy (DCM) to further improve outcomes. The present article will strive to acquaint the reader with the current strategies and state of knowledge.

Entities:  

Keywords:  Epicardial ablation; Myocardial infarction; Structural heart disease; Substrate-based ablation; Ventricular tachycardia

Mesh:

Year:  2017        PMID: 28597213     DOI: 10.1007/s00399-017-0511-5

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  17 in total

1.  Endpoints for ablation of atrial fibrillation.

Authors:  William G Stevenson; Laurence M Epstein
Journal:  Heart Rhythm       Date:  2006-02       Impact factor: 6.343

2.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy.

Authors:  F E Marchlinski; D J Callans; C D Gottlieb; E Zado
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

3.  Early reperfusion during acute myocardial infarction affects ventricular tachycardia characteristics and the chronic electroanatomic and histological substrate.

Authors:  Adrianus P Wijnmaalen; Martin J Schalij; Jan H von der Thüsen; Robert J M Klautz; Katja Zeppenfeld
Journal:  Circulation       Date:  2010-04-19       Impact factor: 29.690

4.  Scar Homogenization Versus Limited-Substrate Ablation in Patients With Nonischemic Cardiomyopathy and Ventricular Tachycardia.

Authors:  Yalçın Gökoğlan; Sanghamitra Mohanty; Carola Gianni; Pasquale Santangeli; Chintan Trivedi; Mahmut F Güneş; Rong Bai; Amin Al-Ahmad; G Joseph Gallinghouse; Rodney Horton; Patrick M Hranitzky; Javier E Sanchez; Salwa Beheiry; Richard Hongo; Dhanunjaya Lakkireddy; Madhu Reddy; Robert A Schweikert; Antonio Dello Russo; Michela Casella; Claudio Tondo; J David Burkhardt; Sakis Themistoclakis; Luigi Di Biase; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2016-11-01       Impact factor: 24.094

5.  Necessity of epicardial ablation for ventricular tachycardia after sequential endocardial approach.

Authors:  Arian Sultan; Jakob Lüker; Boris Hoffmann; Helge Servatius; Ali Aydin; Jana Nührich; Özge Akbulak; Doreen Schreiber; Benjamin Schäffer; Thomas Rostock; Stephan Willems; Daniel Steven
Journal:  Int J Cardiol       Date:  2014-12-03       Impact factor: 4.164

6.  Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.

Authors:  Borislav Dinov; Lukas Fiedler; Robert Schönbauer; Andreas Bollmann; Sascha Rolf; Christopher Piorkowski; Gerhard Hindricks; Arash Arya
Journal:  Circulation       Date:  2013-11-08       Impact factor: 29.690

7.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.

Authors:  Lars Køber; Jens J Thune; Jens C Nielsen; Jens Haarbo; Lars Videbæk; Eva Korup; Gunnar Jensen; Per Hildebrandt; Flemming H Steffensen; Niels E Bruun; Hans Eiskjær; Axel Brandes; Anna M Thøgersen; Finn Gustafsson; Kenneth Egstrup; Regitze Videbæk; Christian Hassager; Jesper H Svendsen; Dan E Høfsten; Christian Torp-Pedersen; Steen Pehrson
Journal:  N Engl J Med       Date:  2016-08-27       Impact factor: 91.245

8.  Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts.

Authors:  P I Gardner; P C Ursell; J J Fenoglio; A L Wit
Journal:  Circulation       Date:  1985-09       Impact factor: 29.690

9.  Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars.

Authors:  Kyoko Soejima; William G Stevenson; John L Sapp; Andrew P Selwyn; Gregory Couper; Laurence M Epstein
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

10.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

View more
  1 in total

1.  The use of a high-resolution mapping system may facilitate standard clinical practice in VE and VT ablation.

Authors:  Arian Sultan; Barbara Bellmann; Jakob Lüker; Tobias Plenge; Jan-Hendrik van den Bruck; Karlo Filipovic; Susanne Erlhöfer; Liz Kuffer; Zeynep Arica; Daniel Steven
Journal:  J Interv Card Electrophysiol       Date:  2019-03-07       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.